1050656-31-9Relevant academic research and scientific papers
COMPOUND FOR INHIBITING PGE2/EP4 SIGNALING TRANSDUCTION INHIBITING, PREPARATION METHOD THEREFOR, AND MEDICAL USES THEREOF
-
, (2022/03/14)
A compound of formula (I), a preparation method therefor, a pharmaceutical composition containing a derivative thereof, and the therapeutic uses thereof, especially inhibiting PGE2/EP4 signalling transduction and the uses thereof for treating cancer, acute or chronic pain, migraine, osteoarthritis, rheumatoid arthritis, gout, bursitis, ankylosing spondylitis, primary dysmenorrhea, tumour or arteriosclerosis.
Discovery of 4-{1-[({1-[4-(trifluoromethyl)benzyl]-1H-indol-7-yl}carbonyl) amino]cyclopropyl}benzoic acid (MF-766), a highly potent and selective EP 4 antagonist for treating inflammatory pain
Colucci, John,Boyd, Michael,Berthelette, Carl,Chiasson, Jean-Francois,Wang, Zhaoyin,Ducharme, Yves,Friesen, Rick,Wrona, Mark,Levesque, Jean-Francois,Denis, Danielle,Mathieu, Marie-Claude,Stocco, Rino,Therien, Alex G.,Clarke, Patsy,Rowland, Steve,Xu, Daigen,Han, Yongxin
scheme or table, p. 3760 - 3763 (2010/09/03)
The discovery of a highly potent and selective EP4 antagonist MF-766 is discussed. This N-benzyl indole derivative exhibits good pharmacokinetic profile and unprecedented in vivo potency in the rat AIA model.
PROCESS FOR MAKING INDOLE CYCLOPROPYL AMIDE DERIVATIVES
-
Page/Page column 9; 11, (2010/11/05)
An efficient and economical process for synthesizing kilogram quantities of an indole cyclopropyl amide derivative of Formula (I), or a pharmaceutically acceptable salt thereof, is disclosed. The process comprises the coupling of indolecarboxylic acid der
INDOLE AND INDOLINE CYCLOPROPYL AMIDE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS
-
Page/Page column 28-29, (2008/12/08)
The invention is directed to indole and indoline cyclopropyl amide derivatives as EP4 receptor antagonists useful for the treatment of EP4 mediated diseases or conditions, such as acute and chronic pain, osteoarthritis, rheumatoid arthritis and cancer. Ph
